BSD Medical Bolsters U.S. MicroThermX Support Team With New Hire

BSD Medical Corporation has hired Shella Leahy to provide technical, clinical, educational and field support for its MicroThermX microwave ablation system in the United States. Leahy will lead educational and training activities with customers and sales representatives throughout the nation.

“We continue to make inroads in the education, adoption, and use of our MicroThermX system in the United States,” said Brian Ferrand, BSD vice president of Domestic Sales at BSD Medical. “To that end, it is imperative we make additional key hires to support our growing base of users. Shella is an exceptional addition to our team with over 15 years of medical device experience. She practiced for many years as a chief technologist using equipment with patients in a hospital environment and more recently worked at a well-known, multi-billion market cap medical device company teaching medical device usage at over 80 hospitals, giving her an excellent foundation from both a customer and sales perspective. She will play an integral part in supporting our distribution agreement efforts in the West with Comed Medical Specialties.”

Leahy joins BSD from Hologic, Inc. a maker of premium diagnostic products, medical imaging systems and surgical products serving the healthcare needs of women, where she was responsible for interfacing with hospitals across California to sell and train them on new diagnostic equipment. Prior to Hologic, she spent more than a decade in hospital and clinical settings involved in all aspects of medical imaging.

BSD’s MicroThermX Microwave Ablation System is a compact, mobile, proprietary system that includes a microwave generator, single-patient-use disposable antennas, and a thermistor-based temperature monitoring system. The company claims the product’s  design is the first of its kind that allows delivery of higher power levels using a single generator. The MicroThermX uses synchronous phased array technology that was developed and patented by BSD to provide larger and more uniform zones of ablation during a single procedure.

The MicroThermX product line includes a high-end disposable that is used in each ablation treatment. The soft tissue ablation world market is valued at $2.3 billion. The MicroThermX is both CE Marked and cleared by the U.S. Food and Drug Administration.

Salt Lake City, Utah-based BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy, which is delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s MicroThermX microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue.